Higher values indicate aggressive inorganic growth strategies, while lower values suggest a focus on organic growth or a pause in M&A activity.
The total value of goodwill recognized on the balance sheet resulting from business acquisitions completed during the re...
Standard metric for companies pursuing growth through strategic acquisitions.
other_goodwill_acquired_during_period| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Innovative Medicine | $273.00M | $57.00M | $20.00M | $0.00 | $2.88B | $0.00 | $642.00M | $0.00 |
| MEDTECH | $7.49B | $73.00M | $2.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | — | — | — | — | — | — | — | — |
CONSUMER HEALTH was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.